LeMaitre Vascular Gross Profit 2010-2025 | LMAT
LeMaitre Vascular gross profit from 2010 to 2025. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
| LeMaitre Vascular Annual Gross Profit (Millions of US $) |
|
|---|---|
| 2024 | $151 |
| 2023 | $127 |
| 2022 | $105 |
| 2021 | $101 |
| 2020 | $85 |
| 2019 | $80 |
| 2018 | $74 |
| 2017 | $71 |
| 2016 | $63 |
| 2015 | $54 |
| 2014 | $48 |
| 2013 | $45 |
| 2012 | $41 |
| 2011 | $40 |
| 2010 | $42 |
| 2009 | $37 |
| LeMaitre Vascular Quarterly Gross Profit (Millions of US $) |
|
|---|---|
| 2025-03-31 | $41 |
| 2024-12-31 | $39 |
| 2024-09-30 | $37 |
| 2024-06-30 | $38 |
| 2024-03-31 | $37 |
| 2023-12-31 | $33 |
| 2023-09-30 | $31 |
| 2023-06-30 | $32 |
| 2023-03-31 | $31 |
| 2022-12-31 | $26 |
| 2022-09-30 | $25 |
| 2022-06-30 | $28 |
| 2022-03-31 | $26 |
| 2021-12-31 | $26 |
| 2021-09-30 | $25 |
| 2021-06-30 | $27 |
| 2021-03-31 | $24 |
| 2020-12-31 | $24 |
| 2020-09-30 | $23 |
| 2020-06-30 | $17 |
| 2020-03-31 | $20 |
| 2019-12-31 | $20 |
| 2019-09-30 | $20 |
| 2019-06-30 | $20 |
| 2019-03-31 | $19 |
| 2018-12-31 | $19 |
| 2018-09-30 | $17 |
| 2018-06-30 | $19 |
| 2018-03-31 | $18 |
| 2017-12-31 | $18 |
| 2017-09-30 | $18 |
| 2017-06-30 | $18 |
| 2017-03-31 | $17 |
| 2016-12-31 | $16 |
| 2016-09-30 | $17 |
| 2016-06-30 | $15 |
| 2016-03-31 | $14 |
| 2015-12-31 | $14 |
| 2015-09-30 | $14 |
| 2015-06-30 | $13 |
| 2015-03-31 | $13 |
| 2014-12-31 | $13 |
| 2014-09-30 | $12 |
| 2014-06-30 | $12 |
| 2014-03-31 | $11 |
| 2013-12-31 | $12 |
| 2013-09-30 | $11 |
| 2013-06-30 | $11 |
| 2013-03-31 | $11 |
| 2012-12-31 | $10 |
| 2012-09-30 | $10 |
| 2012-06-30 | $11 |
| 2012-03-31 | $10 |
| 2011-12-31 | $10 |
| 2011-09-30 | $10 |
| 2011-06-30 | $10 |
| 2011-03-31 | $10 |
| 2010-12-31 | $10 |
| 2010-09-30 | $10 |
| 2010-06-30 | $11 |
| 2010-03-31 | $10 |
| 2009-12-31 | $10 |
| 2009-09-30 | $10 |
| 2009-06-30 | $9 |
| 2009-03-31 | $8 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $1.876B | $0.220B |
| LeMaitre Vascular, Inc. is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects the people worldwide. LeMaitre develops, manufactures, and markets disposable and implantable vascular devices to address the needs of vascular surgeons and interventionalists. LeMaitre's diversified product portfolio consists of twelve well-known brand name products used in arteries and veins outside of the heart and are supported by a growing, specialized and highly trained organization of vascular sales professionals. LeMaitre Vascular offers a wide range of innovative products to vascular surgeons and interventionalists for improving procedure efficacy and minimizing patient recovery time. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $236.635B | 28.45 |
| Boston Scientific (BSX) | United States | $158.907B | 39.78 |
| Stryker (SYK) | United States | $151.008B | 31.58 |
| EssilorLuxottica (ESLOY) | France | $127.124B | 0.00 |
| Medtronic (MDT) | Ireland | $111.799B | 15.85 |
| Lonza Group Ag (LZAGY) | Switzerland | $51.541B | 0.00 |
| Haleon (HLN) | United Kingdom | $46.605B | 26.59 |
| ResMed (RMD) | United States | $37.830B | 28.41 |
| GE HealthCare Technologies (GEHC) | United States | $33.916B | 16.10 |
| Agilent Technologies (A) | United States | $33.522B | 21.85 |
| Terumo (TRUMY) | Japan | $27.168B | 35.29 |
| Koninklijke Philips (PHG) | Netherlands | $23.091B | 16.20 |
| Insulet (PODD) | United States | $22.110B | 86.79 |
| Zimmer Biomet Holdings (ZBH) | United States | $18.046B | 11.59 |
| Baxter (BAX) | United States | $15.539B | 11.60 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.415B | 0.00 |
| Demant (WILYY) | Denmark | $9.110B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $8.561B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $6.567B | 22.85 |
| Lantheus Holdings (LNTH) | United States | $5.664B | 14.29 |
| Prestige Consumer Healthcare (PBH) | United States | $3.946B | 17.63 |
| Perrigo (PRGO) | Ireland | $3.673B | 9.31 |
| Haemonetics (HAE) | United States | $3.584B | 16.33 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.459B | 0.00 |
| Envista Holdings (NVST) | United States | $3.312B | 27.52 |
| ICU Medical (ICUI) | United States | $3.252B | 23.98 |
| QuidelOrtho (QDEL) | United States | $1.949B | 13.40 |
| AtriCure (ATRC) | United States | $1.622B | 0.00 |
| Acuren (TIC) | United States | $1.341B | 0.00 |
| AdaptHealth (AHCO) | United States | $1.273B | 12.92 |
| Green Thumb Industries (GTBIF) | United States | $1.167B | 26.24 |
| Neogen (NEOG) | United States | $1.037B | 13.28 |
| Phibro Animal Health (PAHC) | United States | $1.035B | 13.23 |
| BioLife Solutions (BLFS) | United States | $1.023B | 0.00 |
| InMode (INMD) | Israel | $0.913B | 9.20 |
| Kestra Medical Technologies (KMTS) | United States | $0.851B | 0.00 |
| Owens & Minor (OMI) | United States | $0.703B | 5.83 |
| CeriBell (CBLL) | United States | $0.677B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.614B | 0.00 |
| Evolus (EOLS) | United States | $0.594B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $0.559B | 0.00 |
| Valneva SE (VALN) | France | $0.482B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.454B | 0.00 |
| Surmodics (SRDX) | United States | $0.425B | 0.00 |
| Tilray Brands (TLRY) | Canada | $0.417B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.357B | 13.14 |
| Quanterix (QTRX) | United States | $0.332B | 0.00 |
| SNDL (SNDL) | Canada | $0.318B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.301B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.281B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.273B | 23.03 |
| Cerus (CERS) | United States | $0.270B | 0.00 |
| ZimVie (ZIMV) | United States | $0.260B | 11.84 |
| Sanara MedTech (SMTI) | United States | $0.252B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.252B | 0.00 |
| Brainsway (BWAY) | Israel | $0.248B | 65.75 |
| Aurora Cannabis (ACB) | Canada | $0.238B | 70.67 |
| OraSure Technologies (OSUR) | United States | $0.224B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.224B | 0.00 |
| Biote (BTMD) | United States | $0.220B | 6.18 |
| TriSalus Life Sciences (TLSI) | United States | $0.206B | 0.00 |
| High Tide (HITI) | Canada | $0.187B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.185B | 15.06 |
| Organigram Global (OGI) | Canada | $0.181B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.180B | 0.00 |
| Omeros (OMER) | United States | $0.176B | 0.00 |
| Exagen (XGN) | United States | $0.149B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.143B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.122B | 15.05 |
| Jin Medical (ZJYL) | China | $0.102B | 0.00 |
| Fonar (FONR) | United States | $0.093B | 11.97 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.085B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| Apyx Medical (APYX) | United States | $0.085B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.080B | 0.00 |
| Zynex (ZYXI) | United States | $0.078B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.078B | 0.00 |
| MacroGenics (MGNX) | United States | $0.076B | 0.00 |
| InterCure (INCR) | Israel | $0.067B | 0.00 |
| Agape ATP (ATPC) | $0.066B | 0.00 | |
| Jushi Holdings (JUSHF) | United States | $0.064B | 0.00 |
| ImmuCell (ICCC) | United States | $0.063B | 0.00 |
| Nephros (NEPH) | United States | $0.043B | 58.43 |
| Modular Medical (MODD) | United States | $0.040B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 12.70 |
| Rockwell Medical (RMTI) | United States | $0.029B | 0.00 |
| Safety Shot (SHOT) | United States | $0.025B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.018B | 0.00 |
| INLIF (INLF) | $0.017B | 0.00 | |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| Senestech (SNES) | United States | $0.010B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.006B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | Canada | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |